Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Genes & Diseases
|
November 24, 2025
Simple gene knockout by single gene-directed multiplex CRISPR-Cpf1
Yeon-Ju Jeong, Gyeong-Nam Kim, Jeongin Cho, et al.
Animal Cells and Systems
|
January 6, 2023
Immortalization of primary marmoset skin fibroblasts by CRISPR-Cas9-mediated gene targeting
Yeon-Ju Jeong, Jeongin Cho, Jina Kwak, et al.
International Journal of Molecular Sciences
|
May 27, 2026
CRISPR-Cpf1-Mediated Gene-Editing System Based on a Single Bidirectional Promoter
Soomin Kim, Gyeong-Nam Kim, Yeon-Ju Jeong, et al.
International Journal of Biological Macromolecules
|
April 30, 2024
Yeast-derived particulate beta-glucan induced angiogenesis via regulating PI3K/Src and ERK1/2 signaling pathway
Seung Min Lee, Jin Woo Lee, Jeongin Cho, et al.
International Journal of Biological Macromolecules
|
January 28, 2026
Yeast-derived β-glucan enhances angiogenesis by activating the AMPK-HDAC7-MEF2 axis
Jeongin Cho, Sujin Choi, Seung Min Lee, et al.
Biochemical and Biophysical Research Communications
|
October 7, 2022
Generation of genetically engineered mice for lung cancer with mutant EGFR
Da-Som Kim, Wonjun Ji, Dong Ha Kim, et al.
Biomaterials Research
|
December 16, 2023
HDAC5-mediated exosomal Maspin and miR-151a-3p as biomarkers for enhancing radiation treatment sensitivity in hepatocellular carcinoma
Seung Min Lee, Jeongin Cho, Sujin Choi, et al.
Cancer Research
|
June 14, 2022
The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Cancer Research
|
August 25, 2022
Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Cancer Research
|
August 26, 2022
Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Genes & Diseases
|
November 24, 2025
Simple gene knockout by single gene-directed multiplex CRISPR-Cpf1
Yeon-Ju Jeong, Gyeong-Nam Kim, Jeongin Cho, et al.
Animal Cells and Systems
|
January 6, 2023
Immortalization of primary marmoset skin fibroblasts by CRISPR-Cas9-mediated gene targeting
Yeon-Ju Jeong, Jeongin Cho, Jina Kwak, et al.
International Journal of Molecular Sciences
|
May 27, 2026
CRISPR-Cpf1-Mediated Gene-Editing System Based on a Single Bidirectional Promoter
Soomin Kim, Gyeong-Nam Kim, Yeon-Ju Jeong, et al.
International Journal of Biological Macromolecules
|
April 30, 2024
Yeast-derived particulate beta-glucan induced angiogenesis via regulating PI3K/Src and ERK1/2 signaling pathway
Seung Min Lee, Jin Woo Lee, Jeongin Cho, et al.
International Journal of Biological Macromolecules
|
January 28, 2026
Yeast-derived β-glucan enhances angiogenesis by activating the AMPK-HDAC7-MEF2 axis
Jeongin Cho, Sujin Choi, Seung Min Lee, et al.
Biochemical and Biophysical Research Communications
|
October 7, 2022
Generation of genetically engineered mice for lung cancer with mutant EGFR
Da-Som Kim, Wonjun Ji, Dong Ha Kim, et al.
Biomaterials Research
|
December 16, 2023
HDAC5-mediated exosomal Maspin and miR-151a-3p as biomarkers for enhancing radiation treatment sensitivity in hepatocellular carcinoma
Seung Min Lee, Jeongin Cho, Sujin Choi, et al.
Cancer Research
|
June 14, 2022
The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Cancer Research
|
August 25, 2022
Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Cancer Research
|
August 26, 2022
Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer
Yun Jung Choi, Da-Som Kim, Young Hoon Sung, et al.
Page
of 1